NCT00230061View on ClinicalTrials.gov

Hepatitis B Vaccination in HIV-infected Persons

PHASE4CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

February 28, 2010

Conditions
HIV InfectionsHepatitis B
Interventions
BIOLOGICAL

HBVAXPRO, Hepatitis B (Recombinant) vaccine, 10 mcg/ml

Trial Locations (1)

3000 CA

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Stichting Nuts Ohra

OTHER

lead

Erasmus Medical Center

OTHER